The Pre-Series B funding round saw participation from the company#39;s existing investors, Tiger Global and Blume Ventures, as well as new investors, The Ecosystem Integrity Fund (EIF) and British International Investment (BII).
With this, it has secured 503 marketing approvals for its oncology products across 75 countries, a company statement said.
Reuters reported on Tuesday that private equity firm Fajr is in exclusive talks to buy a majority stake in Aster#39;s Gulf business, citing two sources with direct knowledge of the matter.
The Bengaluru-based company, which mainly deals in fine silver jewellery, has raised this amount in Series B funding led by Premji Invest.
The company has entered into a binding term sheet with Stelis to acquire its Bengaluru-based Unit 3 biologics manufacturing unit, Syngene said in a late night statement on Tuesday.
While equities will fetch steady return over the long term, it makes sense to pocket some gains post a sharp rally
The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said.
GST’s introduction is a momentous occasion in India’s economic history. Here are some steps that can make the GST framework more robust and support growth
Price of domestic LPG cylinders remain unchanged
The company, which raised 43.3 billion rupee ($528 million) in India’s second-largest new share sale this year, has seen its shares jump 57% in almost two months, drawing a rush of buy calls from analysts.
Morgan Stanley and Bank of America Corp. will take the bulk of that pool while the rest will be paid just a token amount, they said, asking not to be identified as the information is not public.A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
